Table 2.
Measurements at 4-weeks | PVN (pg/mg protein)
|
Plasma (pg/ml)
|
|||||
---|---|---|---|---|---|---|---|
TNF-α | IL-1β | IL-6 | TNF-α | IL-1β | IL-6 | ANG II | |
HF + PVN SN50 | 4.0±0.4† | 21.6±2.6† | 26.5±2.5† | 13.2±1.4† | 68.6±6.2† | 45.3±4.2† | 67.4±5.9† |
HF + PVN SN50M | 7.5±0.6* | 53.4±4.7* | 65.4±6.1* | 37.4±3.5* | 119.8±10.7* | 101.7±9.6* | 123.8±10.3* |
HF + PVN vehicle | 7.7±0.6* | 55.1±4.8* | 67.1±6.2* | 38.2±3.6* | 121.7±10.8* | 103.4±9.8* | 126.3±10.5* |
SHAM + PVN SN50 | 3.5±0.4 | 17.3±1.5 | 19.2±1.9 | 10.6±1.3 | 56.4±4.6 | 37.4±3.9 | 57.5±4.7 |
SHAM + PVN SN50M | 3.6±0.4 | 18.7±2.2 | 23.6±2.0 | 11.7±1.4 | 60.9±5.8 | 40.8±4.1 | 61.8±5.2 |
SHAM + PVN vehicle | 3.7±0.4 | 19.4±2.3 | 25.1±2.2 | 12.2±1.4 | 63.7±5.7 | 43.1±4.0 | 64.1±5.4 |
P<0.05 versus SHAM groups.
P<0.05 HF+PVN SN50 versus HF+PVN vehicle or HF+PVN SN50M.